POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management

American Journal of Hematology

Volumn 86, Issue 7, 2011, Pages 591-601

  Dispenzieri, Angela ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN; LENALIDOMIDE; MELPHALAN; PREDNISONE; THALIDOMIDE; VASCULOTROPIN ANTIBODY; VINCRISTINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; CLINICAL FEATURE; CONTINUING EDUCATION; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PLASMA CELL; PLASMACYTOMA; PLASMAPHERESIS; POEMS SYNDROME; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN ALLERGY; STEM CELL TRANSPLANTATION;

DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; POEMS SYNDROME; RISK FACTORS; TIME FACTORS;

EID: 79959370409     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22050     Document Type: Article

References (163)

1. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980; 59: 311-322.
2. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: Clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol 1983; 13: 543-555.
3. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: A study of 102 cases in Japan. Neurology 1984; 34: 712-720.
4. Singh D, Wadhwa J, Kumar L, et al. POEMS syndrome: Experience with fourteen cases. Leuk Lymphoma 2003; 44: 1749-1752.
5. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: A study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 1994; 97: 543-553.
6. Zhang B, Song X, Liang B, et al. The clinical study of POEMS syndrome in China. Neuro Endocrinol Lett 2010; 31: 229-237.
7. Li J, Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 2011.
8. Kulkarni GB, Mahadevan A, Taly AB, et al. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. J Clin Neurosci: Official J Neurosurg Soc Australasia 2011; 18: 356-360.
9. Dispenzieri A. POEMS Syndrome. Blood Rev 2007; 21: 285-299.
10. Watanabe O, Arimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome [letter]. Lancet 1996; 347: 702.
11. Soubrier M, Guillon R, Dubost JJ, et al. Arterial obliteration in POEMS syndrome: Possible role of vascular endothelial growth factor. J Rheumatol 1998; 25: 813-815.
12. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998; 21: 1390-1397.
13. Nishi J, Arimura K, Utsunomiya A, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br J Haematol 1999; 104: 482-485.
14. Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 1999; 34: 633-638.
15. Niimi H, Arimura K, Jonosono M, et al. VEGF is causative for pulmonary hypertension in a patient with Crow- Fukase (POEMS) syndrome. Intern Med 2000; 39: 1101-1104.
16. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: Role of angiogenic factors in the pathogenesis. Brain 2005; 128: 1911-1920.
17. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006; 66: 105-107.
18. Mineta M, Hatori M, Sano H, et al. Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: A case report and review of the literature. Tohoku J Exp Med. 2006; 210: 269-277.
19. Kanai K, Kuwabara S, Misawa S, et al. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med 2007; 46: 311-313.
20. Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006; 107: 4972-4973; author reply 4973-4974.
21. Dietrich PY, Duchosal MA. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 2008; 19: 595.
22. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005; 106: 1135.
23. Ohwada C, Nakaseko C, Sakai S, et al. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 2009; 43: 739-740.
24. Badros A. Bevacizumab therapy for POEMS syndrome. Blood 2006; 107: author reply 4973-4974.
25. Samaras P, Bauer S, Stenner-Liewen F, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007; 92: 1438-1439.
26. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: Evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheumatism 1997; 40: 786-787.
27. Endo I, Mitsui T, Nishino M, et al. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Inter Med 2002; 41: 1196-1198.
28. Nakano A, Mitsui T, Endo I, et al. Solitary plasmacytoma with VEGF overproduction: Report of a patient with polyneuropathy. Neurology 2001; 56: 818-819.
29. Koga H, Tokunaga Y, Hisamoto T, et al. Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med 2002; 13: 70-74.
30. Soubrier M, Labauge P, Jouanel P, et al. Restricted use of Vlambda genes in POEMS syndrome. Haematologica 2004; 89: ECR02.
31. Nakaseko C, Abe D, Takeuchi M, et al. Restricted oligo-clonal usage of monoclonal immunoglobulin {lambda} light chain germline in poems syndrome. ASH Annual Meeting Abstracts 2007; 110: 2483-
32. Aravamudan B, Tong C, Lacy MQ, et al. Immunoglobulin variable light chain restriction, cytokine expression and plasma cell-stromal cell interactions in POEMS syndrome patients. ASH Annual Meeting Abstracts 2008; 112: 2744.
33. Bryce AH, Ketterling RP, Gertz MA, et al. Cytogenetic analysis using multiple myeloma targets in POEMS syndrome. Proceedings of American Society of Oncology Meeting. Chicago, IL; 2007.
34. Alberti MA, Martinez-Yelamos S, Fernandez A, et al. 18F-FDG PET/CT in the evaluation of POEMS syndrome. Eur J Radiol 2010; 76: 180-182.
35. Nobile-Orazio E, Terenghi F, Giannotta C, et al. Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology 2009; 72: 1024-1026.
36. Briani C, Fabrizi GM, Ruggero S, et al. Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. Muscle Nerve 2010; 43: 164-167.
37. Dao LN, Hanson CA, Dispenzieri A, et al. Bone marrow histopathology in POEMS syndrome: A distinctive combination of plasma cell, lymphoid and myeloid findings in 87 patients. Blood 2011 blood-2010-11-316935; published ahead of print March 8, 2011, doi:10.1182/blood-2010-11-316935.
38. Dispenzieri A. Castleman disease. Cancer Treat Res 2008; 142: 293-330.
39. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003; 101: 2496-2506.
40. Kelly JJ, Jr., Kyle RA, Miles JM, et al. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983; 33: 202-210.
41. Koike H, Iijima M, Mori K, et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008; 79: 1171-1179.
42. Kaushik M, Pulido JS, Abreu R, et al. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology 2011; 118(4): 778-782.
43. Barete S, Mouawad R, Choquet S, et al. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: Impact of autologous hematopoietic stem cell transplantation. Arch Dermatol 2010; 146: 615-623.
44. Allam JS, Kennedy CC, Aksamit TR, et al. Pulmonary manifestations in patients with POEMS syndrome: A retrospective review of 137 patients. Chest 2008; 133: 969-974.
45. Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: A new feature of the POEMS syndrome? Medicine 1996; 75: 226-232.
46. Dupont SA, Dispenzieri A, Mauermann ML, et al. Cerebral infarction in POEMS syndrome: Incidence, risk factors, and imaging characteristics. Neurology 2009; 73: 1308-1312.
47. Saida K, Kawakami H, Ohta M, et al. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 1997; 20: 486-492.
48. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000; 23: 1051-1056.
49. Loeb JM, Hauger PH, Carney JD, et al. Refractory ascites due to POEMS syndrome. Gastroenterology 1989; 96: 247-249.
50. Tokashiki T, Hashiguchi T, Arimura K, et al. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Intern Med 2003; 42: 1240-1243.
51. Stankowski-Drengler T, Gertz MA, Katzmann JA, et al. Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. Am J Hematol 2010; 85: 431-434.
52. Sanada S, Ookawara S, Karube H, et al. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Am J Kidney Dis 2006; 47: 672-679.
53. Navis GJ, Dullaart RP, Vellenga E, et al. Renal disease in POEMS syndrome: Report on a case and review of the literature. [Review] [25 refs]. Nephrol Dialysis Transplantat 1994; 9: 1477-1481.
54. Viard JP, Lesavre P, Boitard C, et al. POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med 1988; 84: 524-528.
55. Sano M, Terasaki T, Koyama A, et al. Glomerular lesions associated with the Crow-Fukase syndrome. Virchows Archiv A, Pathological Anat Histopathol 1986; 409: 3-9.
56. Takazoe K, Shimada T, Kawamura T, et al. Possible mechanism of progressive renal failure in Crow-Fukase syndrome [letter]. Clin Nephrol 1997; 47: 66-67.
57. Mizuiri S, Mitsuo K, Sakai K, et al. Renal involvement in POEMS syndrome. Nephron 1991; 59: 153-156.
58. Stewart PM, McIntyre MA, Edwards CR. The endocrinopathy of POEMS syndrome. Scott Med J 1989; 34: 520-522.
59. Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dialysis Transplantat 1999; 14: 2370-2378.
60. Fukatsu A, Ito Y, Yuzawa Y, et al. A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron 1992; 62: 47-51.
61. Ghandi GY, Basu R, Dispenzieri A, et al. Endocrinopathy in POEMS Syndrome: The Mayo Clinic Experience. Mayo Clin Proc 2007; 82: 836-842.
62. Tanaka O, Ohsawa T. The POEMS syndrome: Report of three cases with radiographic abnormalities. Radiologe 1984; 24: 472-474.
63. Chong ST, Beasley HS, Daffner RH. POEMS syndrome: Radiographic appearance with MRI correlation. Skeletal Radiol 2006; 35: 690-695.
64. Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines. Am J Respiratory Crit Care Med 1998; 157: 907-911.
65. Ishikawa O, Nihei Y, Ishikawa H. The skin changes of POEMS syndrome. Br J Dermatol 1987; 117: 523-526.
66. Jitsukawa K, Hayashi Y, Sato S, et al. Cutaneous angioma in Crow-Fukase syndrome: The nature of globules within the endothelial cells. J Dermatol 1988; 15: 513-522.
67. Rongioletti F, Gambini C, Lerza R. Glomeruloid hemangioma. A cutaneous marker of POEMS syndrome. Am J Dermatopathol 1994; 16: 175-178.
68. Santoro L, Manganelli F, Bruno R, et al. Sural nerve and epidermal vascular abnormalities in a case of POEMS syndrome. Eur J Neurol: Official J Eur Federation Neurological Soc 2006; 13: 99-102.
69. Kelly JJJr. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve 1983; 6: 504-509.
70. Sung JY, Kuwabara S, Ogawara K, et al. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 2002; 26: 189-193.
71. Min JH, Hong YH, Lee KW. Electrophysiological features of patients with POEMS syndrome. Clin Neurophysiol 2005; 116: 965-968.
72. Vital C, Vital A, Ferrer X, et al. Crow-Fukase (POEMS) syndrome: A study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 2003; 8: 136-144.
73. Orefice G, Morra VB, De Michele G, et al. POEMS syndrome: Clinical, pathological and immunological study of a case. Neurological Res 1994; 16: 477-480.
74. Crisci C, Barbieri F, Parente D, et al. POEMS syndrome: Follow-up study of a case. Clin Neurol Neurosurg 1992; 94: 65-68.
75. Bergouignan FX, Massonnat R, Vital C, et al. Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol 1987; 27: 173-181.
76. Khuda SE, Loo WM, Janz S, et al. Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors. J Immunol 2008; 181: 7537-7549.
77. Arimura K. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome]. [Jap]. Rinsho Shinkeigaku Clin Neurol 1999; 39: 84-85.
78. Dispenzieri A, Moreno-Aspitia A, Lacy MQ, et al. Peripheral blood stem cell transplant (PBSCT) in a large series of patients with POEMS syndrome. Biol Blood Marrow Tr 2004; 10: 14-15.
79. Shirabe S, Kishikawa M, Mine M, et al. Crow-Fukase syndrome associated with extramedullary plasmacytoma. Jap J Med 1991; 30: 64-66.
80. Thajeb P, Chee CY, Lo SF, et al. The POEMS syndrome among Chinese: Association with Castleman's disease and some immunological abnormalities. Acta Neurologica Scandinavica 1989; 80: 492-500.
81. Papo T, Soubrier M, Marcelin AG, et al. Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome [letter]. Br J Haematol 1999; 104: 932-933.
82. Vital C, Gherardi R, Vital A, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathologica 1994; 87: 302-307.
83. Yang SG, Cho KH, Bang YJ, et al. A case of glomeruloid hemangioma associated with multicentric Castleman's disease. Am J Dermatopathol 1998; 20: 266-270.
84. Kobayashi H, Ii K, Sano T, et al. Plasma-cell dyscrasia with polyneuropathy and endocrine disorders associated with dysfunction of salivary glands. Am J Surg Pathol 1985; 9: 759-763.
85. Bitter M, Komaiko W, Franklin W. Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki's) syndrome. Cancer 1985; 56: 188-194.
86. Lapresle J, Lacroix-Ciaudo C, Reynes M, et al. [Crow-Fukase syndrome (POEMS syndrome) and osseous mastocytosis secondary to Castleman's angiofollicular lymphoid hyperplasia]. [French]. Revue Neurologique 1986; 142: 731-737.
87. Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol 1988; 413: 357-365.
88. Dworak O, Tschubel K, Zhou H, et al. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: A case report with immunohistochemical study]. [German]. Klinische Wochenschrift 1988; 66: 591-595.
89. Rolon PG, Audouin J, Diebold J, et al. Multicentric angiofollicular lymph node hyperplasia associated with a solitary osteolytic costal IgG lambda myeloma. POEMS syndrome in a South American (Paraguayan) patient. Pathol Res Practice 1989; 185: 468-475.
90. Carcaterra A, Santini R, Sozzi G, et al. [Crow-Fukase syndrome (POEMS syndrome). The first Italian presentation of a case and review of the literature]. [Review] [33 refs] [Italian]. Giornale Italiano di Dermatologia e Venereologia 1990; 125: 97-103.
91. Chan JK, Fletcher CD, Hicklin GA, et al. Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol 1990; 14: 1036-1046.
92. Brazis PW, Liesegang TJ, Bolling JP, et al. When do optic disc edema and peripheral neuropathy constitute poetry? Survey Ophthalmol 1990; 35: 219-225.
93. Munoz G, Geijo P, Moldenhauer F, et al. Plasmacellular Castleman's disease and POEMS syndrome. Histopathology 1990; 17: 172-174.
94. Gherardi RK, Malapert D, Degos JD. Castleman disease-POEMS syndrome overlap [letter; comment]. Ann Inter Med 1991; 114: 520-521.
95. Myers BM, Miralles GD, Taylor CA, et al. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med 1991; 90: 646-648.
96. Coto V, Auletta M, Oliviero U, et al. POEMS syndrome: An Italian case with diagnostic and therapeutic implications. Annali Italiani di Medicina Interna 1991; 6: 416-419.
97. Bosco J, Pathmanathan R. POEMS syndrome, osteosclerotic myeloma and Castleman's disease: A case report. Australian New Zealand J Med 1991; 21: 454-456.
98. Mandler RN, Kerrigan DP, Smart J, et al. Castleman's disease in POEMS syndrome with elevated interleukin-6 [see comments]. Cancer 1992; 69: 2697-2703.
99. Nakazawa K, Itoh N, Shigematsu H, et al. An autopsy case of Crow-Fukase (POEMS) syndrome with a high level of IL-6 in the ascites. Special reference to glomerular lesions. Acta Pathologica Japonica 1992; 42: 651-656.
100. Emile C, Danon F, Fermand JP, et al. Castleman disease in POEMS syndrome with elevated interleukin-6 [letter; comment]. Cancer 1993; 71: 874.
101. Judge MR, McGibbon DH, Thompson RP. Angioendotheliomatosis associated with Castleman's lymphoma and POEMS syndrome. Clin Exp Dermatol 1993; 18: 360-362.
102. Del Rio R, Alsina M, Monteagudo J, et al. POEMS syndrome and multiple angioproliferative lesions mimicking generalized histiocytomas. Acta Dermato Venereologica 1994; 74: 388-390.
103. Bhatia M, Maheshwari MC. Angiofollicular lymphoid hyperplasia presenting as POEMS syndrome. J Assoc Phys India 1994; 42: 751-752.
104. Adelman HM, Cacciatore ML, Pascual JF, et al. Case report: Castleman disease in association with POEMS. Am J Med Sci 1994; 307: 112-114.
105. Pareyson D, Marazzi R, Confalonieri P, et al. The POEMS syndrome: Report of six cases. Italian J Neurological Sci 1994; 15: 353-358.
106. Ku A, Lachmann E, Tunkel R, et al. Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome. Arch Phys Med Rehab 1995; 76: 692-694.
107. Huang CC, Chu CC. Poor response to intravenous immunoglobulin therapy in patients with Castleman's disease and the POEMS syndrome [letter; comment]. J Neurol 1996; 243: 726-727.
108. Chang YJ, Huang CC, Chu CC. Intravenous immunoglobulin therapy in POEMS syndrome: A case report. Chung Hua i Hsueh Tsa Chih Chinese Med J 1996; 58: 366-369.
109. Forster A, Muri R. [Recurrent cerebrovascular insult-manifestation of POEMS syndrome?]. [German]. Schweizerische Medizinische Wochenschrift J Suisse de Medecine 1998; 128: 1059-1064.
110. Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 1999; 93: 3643-3653.
111. Belec L, Authier FJ, Mohamed AS, et al. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease. Clin Infect Dis 1999; 28: 678-679.
112. Gaba AR, Stein RS, Sweet DL, et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86-90.
113. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: Association with monoclonal gammopathy. Mayo Clinic Proceedings 1982; 57: 379-382.
114. Black DA, Forgacs I, Davies DR, et al. Pseudotumour cerebri in a patient with Castleman's disease. Postgraduate Med J 1988; 64: 217-219.
115. Feigert JM, Sweet DL, Coleman M, et al. Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome [see comments]. Ann Inter Med 1990; 113: 362-367.
116. Menke DM, Tiemann M, Camoriano JK, et al. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol 1996; 105: 268-276.
117. Mallory A, Spink WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med 1968; 69: 305-308.
118. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1984. N Engl J Med 1984; 311: 388-398.
119. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1987. A 59-year-old woman with progressive polyneuropathy and monoclonal gammopathy. New England J Med 1987; 316: 606-618.
120. Yu GS, Carson JW. Giant lymph-node hyperplasia, plasma-cell type, of the mediastinum, with peripheral neuropathy. Am J Clin Pathol 1976; 66: 46-53.
121. Weisenburger DD, Nathwani BN, Winberg CD, et al. Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases. Hum Pathol 1985; 16: 162-172.
122. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: Association with monoclonal gammopathy. Mayo Clin Proc 1982; 57: 379-382.
123. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989; 89: 253-267.
124. Ganti AK, Pipinos I, Culcea E, et al. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol 2005; 79: 206-210.
125. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: A comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992; 5: 525-530.
126. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989; 89: 253-267.
127. Giglia F, Chiapparini L, Fariselli L, et al. POEMS syndrome: Relapse after successful autologous peripheral blood stem cell transplantation. Neuromuscul Disord 2007; 17: 980-982.
128. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104: 3400-3407.
129. Schliamser LM, Hardan I, Sharif D, et al. Significant Improvement of POEMS syndrome with pulmonary hypertension following autologous peripheral blood stem cell transplant. Blood 2003; 102: 5664 abstract.
130. Soubrier M, Ruivard M, Dubost JJ, et al. Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant 2002; 30: 61-62.
131. Peggs KS, Paneesha S, Kottaridis PD, et al. Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant 2002; 30: 401-404.
132. Jaccard A, Royer B, Bordessoule D, et al. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002; 99: 3057-3059.
133. Rovira M, Carreras E, Blade J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001; 115: 373-375.
134. Hogan WJ, Lacy MQ, Wiseman GA, et al. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2001; 28: 305-309.
135. Dispenzieri A, Lacy MQ, Hayman SR, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008; 80: 397-406.
136. Kuwabara S, Misawa S, Kanai K, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology 2008; 71: 1691-1695.
137. Laurenti L, De Matteis S, Sabatelli M, et al. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leuk Res 2008; 32: 1309-1312.
138. Imai N, Taguchi J, Yagi N, et al. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation. Neuromuscul Disord 2009; 19: 363-365.
139. Kojima H, Katsuoka Y, Katsura Y, et al. Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue. Int J Hematol 2006; 84: 182-185.
140. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007; 110: 1075-1076.
141. Jaccard A, Abraham J, Recher C, et al. Lenalidomide therapy in nine patients with POEMS syndrome. ASH Ann Meeting Abstr 2009; 114: 3872-
142. Tang X, Shi X, Sun A, et al. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009; 83: 609-610.
143. Kaygusuz I, Tezcan H, Cetiner M, et al. Bortezomib: A new therapeutic option for POEMS syndrome. Eur J Haematol 2010; 84: 175-177.
144. Terracciano C, Fiore S, Doldo E, et al. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin. Muscle Nerve 2010; 42: 445-448.
145. Goto H, Nishio M, Kumano K, et al. Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation. Bone Marrow Transplant 2008; 42: 627-629.
146. Li J, Zhang W, Li J, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 2011 blood-2010-12-328112; published ahead of print March 10, 2011, doi:10.1182/blood-2010-12-328112.
147. Dispenzieri A. Ushering in a New Era for POEMS. Blood, in press.
148. Morley JB, Schwieger AC. The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurg Psychiatry 1967; 30: 432-442.
149. Davis L, Drachman D. Myeloma neuropathy. Arch Neurol 1972; 27: 507-511.
150. Iwashita H, Ohnishi A, Asada M, et al. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology 1977; 27: 675-681.
151. Reitan JB, Pape E, Fossa SD, et al. Osteosclerotic myeloma with polyneuropathy. Acta Medica Scandinavica 1980; 208: 137-144.
152. Arima F, Dohmen K, Yamano Y, et al. [Five cases of Crow-Fukase syndrome]. [Japanese]. Fukuoka Igaku Zasshi Fukuoka Acta Medica 1992; 83: 112-120.
153. Wong VA, Wade NK. POEMS syndrome: An unusual cause of bilateral optic disk swelling. Am J Ophthalmol 1998; 126: 452-454.
154. Wiesmann A, Weissert R, Kanz L, et al. Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation. Blood 2002; 100: 2679-2680.
155. Dispenzieri A, Kyle RA, Lacy MQ, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study. Blood 2004; 103: 3960-3963.
156. Takai K, Niikuni K, Kurasaki T. [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation]. Rinsho Ketsueki 2004; 45: 1111-1114.
157. Kastritis E, Terpos E, Anagnostopoulos A, et al. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support. Clin Lymphoma Myeloma 2006; 7: 73-76.
158. Imai N, Kitamura E, Tachibana T, et al. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy. Intern Med 2007; 46: 135-138.
159. Sinisalo M, Hietaharju A, Sauranen J, et al. Thalidomide in POEMS syndrome: Case report. Am J Hematol 2004; 76: 66-68.
160. Kim SY, Lee SA, Ryoo HM, et al. Thalidomide for POEMS syndrome. Ann Hematol 2006; 85: 545-546.
161. Kuwabara S, Misawa S, Kanai K, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008; 79: 1255-1257.
162. Ohguchi H, Ohba R, Onishi Y, et al. Successful treatment with bortezomib and thalidomide for POEMS syndrome. Ann Hematol 2010.
163. Sobas MA, Alonso Vence N, Diaz Arias J, et al. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant). Ann Hematol 2010; 89: 217-219.